Pulmonary arteritis is a very rare manifestation of granulomatosis with polyangiitis, which typically involves small- and medium-sized vessels. But this case highlights the possibility of large-vessel inflammation.
A systematic evaluation of the evidence for accelerated infusion of rituximab in people autoimmune rheumatic diseases. The practice appears safe and feasible but prospective studies are needed.
Adding a conventional synthetic disease-modifying antirheumatic drug to first-line systemic corticosteroid therapy may reduce treatment failure in patients with nonanterior sarcoidosis-associated uveitis.
VEXAS syndrome is a recently identified genetic autoinflammatory disorder. This case highlights its under-recognized renal manifestations and underscores the need for heightened clinical suspicion and earlier intervention.
Tocilizumab has emerged as a promising treatment option for giant cell arteritis, demonstrating significant potential to reduce glucocorticoid dependence. But unanswered questions remain, such as the optimal duration of therapy.
Pulmonary arteritis is a very rare manifestation of granulomatosis with polyangiitis, which typically involves small- and medium-sized vessels. But this case highlights the possibility of large-vessel inflammation.
VEXAS syndrome is a recently identified genetic autoinflammatory disorder. This case highlights its under-recognized renal manifestations and underscores the need for heightened clinical suspicion and earlier intervention.
Two patients presenting with anterior chest pain were diagnosed with Takayasu arteritis co-existing with SAPHO syndrome, a rare inflammatory osteoarticular disorder. Their symptoms improved with glucocorticoids and biologic agents.
Takayasu arteritis (TAK) is a large vessel vasculitis characterized by granulomatous inflammation of aorta and its major branches [ 1 ]. It mainly occurs in young female patients and is much less common among children than adults [ 2 ]. The annual …
Kawasaki disease (KD) is a systemic vasculitis that usually affects children below 5 years and has now become the leading cause of acquired heart disease in children, surpassing acute rheumatic fever. Incidence data from Chandigarh, India, between …
Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare, severe form of urticarial vasculitis. It is characterized by persistent hypocomplementemia, chronic urticarial vasculitic lesions, and severe multiorgan involvement. Herein, we …
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) predominantly affect individuals aged 55–75 years, with granulomatosis with polyangiitis (GPA) being diagnosed most often between 55 and 65 years and microscopic polyangiitis …
Takayasu arteritis (TAK) is a large vessel vasculitis characterized by granulomatous inflammation of aorta and its major branches [ 1 ]. It mainly occurs in young female patients and is much less common among children than adults [ 2 ]. The annual …
The Intravitreal injections (IVI) of anti-vascular endothelial growth factor (VEGF) agents are commonly used as the treatment of choice for patients with macular neovascularization or macular edema from different etiologies, aiming to improve both …
It is known that COVID-19 patients may experience endothelial cell inflammation, apoptosis, dysfunction, and systemic coagulation disorders. In CABG operations, graft patency plays a crucial role in survival and morbidity. Thrombosis and …
Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare, severe form of urticarial vasculitis. It is characterized by persistent hypocomplementemia, chronic urticarial vasculitic lesions, and severe multiorgan involvement. Herein, we …
